Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A3302 CGI-17461 CitationTarget: BTKSummary: Btk inhibitor -
A3415 Firategrast1 CitationSummary: α4β1/α4β7 integrin antagonist -
B3708 RGD (Arg-Gly-Asp) Peptides1 CitationTarget: Integrin-ligand interactionsSummary: Inhibits integrin binding to RGD motifs -
B7412 RGDS peptideSummary: Integrin binding sequence that inhibits integrin receptor function -
B5391 Echistatin, α1 isoformSummary: Potent irreversible αVβ3 integrin antagonist -
B5644 LDV FITCSummary: fluorescent ligand that binds to the α4β1 integrin (VLA-4) -
B5675 ObtustatinSummary: integrin α1β1 inhibitor -
B5699 P11Summary: antagonist of the integrin αvβ3-vitronectin interaction -
B6664 GR 144053 trihydrochlorideSummary: platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist -
B6764 Combretastatin A4Summary: tubulin polymerization inhibitor

